Outcomes of giant cell tumors around the foot and ankle: A pilot study

Moataz A. Elsayed; Ahmed A. Shamma; Mahmoud Seddik  Hasan; Mohamed G. Abdelkader; Mohamed Adel A Ibrahim

doi:10.23750/abm.v96i6.17489

Outcomes of giant cell tumors around the foot and ankle: A pilot study

Authors

Moataz A. Elsayed Orthopaedic department, Faculty of medicine, Al-Azhar university- Al mokhayyam Al Dayem Street, Nasr City, Cairo, Egypt
Ahmed A. Shamma Orthopaedic department, Faculty of medicine, Al-Azhar university- Al mokhayyam Al Dayem Street, Nasr City, Cairo, Egypt
Mahmoud Seddik Hasan Orthopaedic department, Faculty of medicine, Al-Azhar university- Al mokhayyam Al Dayem Street, Nasr City, Cairo, Egypt
Mohamed G. Abdelkader Orthopaedic department, Faculty of medicine, Al-Azhar university- Al mokhayyam Al Dayem Street, Nasr City, Cairo, Egypt
Mohamed Adel A Ibrahim Orthopaedic department, Faculty of medicine, Al-Azhar university- Al mokhayyam Al Dayem Street, Nasr City, Cairo, Egypt https://orcid.org/0000-0002-1796-4549

Keywords:

ankle, cement, curettage, giant cell tumor, foot

Abstract

Objective: The giant cell tumor (GCT) of bone is a benign primary bone tumor that frequently exhibits aggressive behavior and a propensity for local recurrence, which is influenced by the treatment modality and the tumor's local characteristics. This study aimed to assess the efficiency, safety, recurrence and functional outcome of using the technique of extended curettage and cementation for the surgical management of GCT around the foot and ankle.

Methods: Nine male and three female patients who had GCT around their ankle or foot were included. The average age was 33 years, with an average follow-up period of 12 months. Three patients had lesions in the distal tibia, one patient had lesions in the lateral malleolus, four patients had lesions in the talus, three patients had lesions in the calcaneus, and the remaining patient had lesions in the 1^st metatarsal bone.

Results: All patients experienced outstanding functional and satisfying results. No recurrence or damage to adjacent tissues was noted, and no serious intraoperative or postoperative problems were reported. There is a highly significant improvement of the American Orthopaedic Foot and Ankle Society (AOFAS) score with an average of 27.92 ± 5.42, which increased from 69.17 ± 5.97 preoperatively to 97.08 ± 3.34 postoperatively.

Conclusion: Based on our study results, the technique of extended curettage and cementation is a valid option for treating GCT because, in contrast to cement's mechanical and cytotoxic properties, it provides exceptional safety results, ease of handling, and positive post-operative outcomes with no functional problems or recurrences.

References

1. Toepfer A, Harrasser N, Recker M, et al. Distribution patterns of foot and ankle tumors: a university tumor institute experience. BMC Cancer. 2018;18(1):735. doi: 10.1186/s12885-018-4648-3.

2. Co HL, Wang EH. Giant cell tumor of the small bones of the foot. J Orthop Surg 2018;26:1–5. doi: 10.1177/2309499018801168.

3. Ebeid WA, Abo Senna WG, Mohamed MS, et al. Long-term outcome of giant cell tumors around the knee with associated pathological fractures treated by curettage and cementation. J Musculoskelet Surg Res 2019;3:273-8. doi: 10.4103/jmsr.jmsr_33_19.

4. Olvi LG, Lembo GM, Velan O, Cunha IWd, Santini-Araujo E, Kalil RK. Aneurysmal Bone Cyst. In: Tumors and Tumor-Like Lesions of Bone. 2nd ed. Springer Nature Switzerland AG; 2020; P. 631-77. doi:10.1007/978-3-030-29676-6.

5. Verschoor A, Bovée J, Mastboom M, Sander Dijkstra P, Van De Sande M, Gelderblom H. Incidence and Demographics of Giant Cell Tumor of Bone in The Netherlands: First Nationwide Pathology Registry Study. Acta Orthop. 2018;89(5):570-74. doi: 10.1080/17453674.2018.1490987.

6. Moreira FD, Santili C, Guedes A, Paz CL da SL, Barreto BG, Mattos E de SR de. Bone tumors of the foot and ankle - A protocol for systematic review. Res Soc Dev. 2022;11(5):e56111528741. doi:10.33448/rsd-v11i5.28741.

7. Montgomery C, Couch C, Emory CL, Nicholas R. Giant Cell Tumor of Bone: Review of Current Literature, Evaluation, and Treatment Options. J Knee Surg. 2019;32(4):331-36. doi: 10.1055/s-0038-1675815.

8. Parmeggiani A, Miceli M, Errani C, Facchini G. State of the Art and New Concepts in Giant Cell Tumor of Bone: Imaging Features and Tumor Characteristics. Cancers (Basel). 2021;13(24):6298. doi: 10.3390/cancers13246298.

9. Hasenfratz M, Mellert K, Marienfeld R, et al. Profiling of three H3F3A-mutated and denosumab-treated giant cell tumors of bone points to diverging pathways during progression and malignant transformation. Sci Rep. 2021;11(1):5709. doi: 10.1038/s41598-021-85319-x.

10. Rizzo A, Paderno M, Saccomanno MF, Milano F, Milano G. The Musculoskeletal Tumor Society Scoring system is a valid subjective and objective tool to evaluate outcomes of surgical treatment of patients affected by upper and lower extremity tumors. Musculoskelet Surg. 2024;108(2):201-14. doi: 10.1007/s12306-024-00815-3.

11. Ibrahim T, Beiri A, Azzabi M, Best AJ, Taylor GJ, Menon DK. Reliability and validity of the subjective component of the American Orthopaedic Foot and Ankle Society clinical rating scales. J Foot Ankle Surgery. 2007; 46:65–74. doi: 10.1053/j.jfas.2006.12.002.

12. Rajani R, Schaefer L, Scarborough MT, Gibbs CP. Giant Cell Tumors of the Foot and Ankle Bones: High Recurrence Rates After Surgical Treatment. J Foot Ankle Surg.2015;54(6):1141-45. doi: 10.1053/j.jfas.2014.08.016.

13. Biscaglia R, Bacchini P, Bertoni F. Giant cell tumor of the bones of the hand and foot. Cancer.2000;88(9):2022-32.doi:10.1002/(sici)1097-0142(20000501)88:9<2022::aid cncr6>3.0.co;2-y.

14. Athanasian EA, Wold LE, Amadio PC. Giant cell tumors of the bones of the hand. J Hand Surg Am.1997;22(1):91-98. doi: 10.1016/S0363-5023(05)80187-X.

15. Paul AJ, Shreemal BB, Titus VTK. Foot and Ankle Giant Cell Tumors Are Not so Aggressive After All: A Retrospective Study. J Foot Ankle Surg. 2021 Jan-Feb;60(1):176-81. doi: 10.1053/j.jfas.2020.07.004.

16. Kamath S, Jane M, Reid R. Giant cell tumor around the foot and ankle. Foot ankle surgery.2006;12(2):99-02.‏ doi:10.1016/j.fas.2006.02.001

17. Chang CY, Garner HW, Ahlawat S, et al. Society of Skeletal Radiology- white paper. Guidelines for the diagnostic management of incidental solitary bone lesions on CT and MRI in adults: bone reporting and data system (Bone-RADS). Skeletal Radiol. 2022;51(9):1743-64. doi: 10.1007/s00256-022-04022-8.

18. Tahir I, Andrei V, Pollock R, Saifuddin A. Skeletal Radiol. Malignant giant cell tumour of bone: a review of clinical, pathological and imaging features. 2022;51:957–70. doi: 10.1007/s00256-021-03913-6.

19. Bombardier B, Haase D, Sweeney K, Friedman E, Poppe T, Hughes N. A comparison of depth of necrosis among adjuvant therapies used for the treatment of benign bone tumors. J Surg Oncol. 2021;123(5):1299-03. doi: 10.1002/jso.26397.

20. Pan KS, Boyce AM. Denosumab Treatment for Giant Cell Tumors, Aneurysmal Bone Cysts, and Fibrous Dysplasia—Risks and Benefits. Curr Osteoporos Rep. 2021;19(2):141-50. doi: 10.1007/s11914-021-00657-z.